| Literature DB >> 34209047 |
Apisada Jiso1,2, Philipp Demuth1, Madeleine Bachowsky1, Manuel Haas1, Nina Seiwert1, Daniel Heylmann3, Birgit Rasenberger4, Markus Christmann4, Lea Dietrich5, Thomas Brunner5, Till F Schäberle6,7, Anuchit Plubrukarn2, Jörg Fahrer1,3.
Abstract
Colorectal cancer (CRC) is a frequently occurring malignant disease with still low survival rates, highlighting the need for novel therapeutics. Merosesquiterpenes are secondary metabolites from marine sponges, which might be useful as antitumor agents. To address this issue, we made use of a compound library comprising 11 isolated merosesquiterpenes. The most cytotoxic compounds were smenospongine > ilimaquinone ≈ dactylospontriol, as shown in different human CRC cell lines. Alkaline Comet assays and γH2AX immunofluorescence microscopy demonstrated DNA strand break formation in CRC cells. Western blot analysis revealed an activation of the DNA damage response with CHK1 phosphorylation, stabilization of p53 and p21, which occurred both in CRC cells with p53 knockout and in p53-mutated CRC cells. This resulted in cell cycle arrest followed by a strong increase in the subG1 population, indicative of apoptosis, and typical morphological alterations. In consistency, cell death measurements showed apoptosis following exposure to merosesquiterpenes. Gene expression studies and analysis of caspase cleavage revealed mitochondrial apoptosis via BAX, BIM, and caspase-9 as the main cell death pathway. Interestingly, the compounds were equally effective in p53-wild-type and p53-mutant CRC cells. Finally, the cytotoxic activity of the merosesquiterpenes was corroborated in intestinal tumor organoids, emphasizing their potential for CRC chemotherapy.Entities:
Keywords: DNA damage; apoptosis; chemotherapy; colorectal cancer; natural compounds; tumor suppressor p53
Year: 2021 PMID: 34209047 DOI: 10.3390/cancers13133282
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639